Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 159, Issue , 2002, Pages 123-133

  Liu, Zhensheng ^a   Savoldo, Barbara ^a   Huls, Helen ^a   Lopez, Teresita ^a   Gee, Adrian ^a   Wilson, Jeffery ^a   Brenner, Malcolm K ^a   Heslop, Helen E ^a   Rooney, Cliona M ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CELL LINE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; IMMUNOLOGY; LYMPHOMA; METHODOLOGY; POSTOPERATIVE COMPLICATION; TRANSPLANTATION; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOMA; POSTOPERATIVE COMPLICATIONS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036357480     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-56352-2_15     Document Type: Article

References (0)